Written by:

Every day around the world billions of people are trying to balance living their lives with the challenges of living with chronic diseases. For all these people, we endeavour to transform healthcare, change their lives for the better and address some of the biggest healthcare challenges facing humankind. 

More than 1.5 billion people around the world live with chronic diseases. That equates to one in every five people. These diseases, which include cardiovascular, renal, metabolic, respiratory and immunological conditions, are leading causes of death across the globe, collectively responsible for approximately 24 million deaths each year. 

And this trend is only set to continue – the top five causes of death globally by 2040 are predicted to include​ cardiovascular disease, chronic obstructive pulmonary disorder, chronic kidney disease and diabetes.

As more people develop these progressive conditions, not only does the rate of personal suffering increase, but so does the cost of care. In the next decade alone, $47 trillion is expected to be spent managing chronic diseases.

Our ambition in BioPharmaceuticals is to intervene earlier to protect vital organs, slow or reverse disease progression, and achieve remission for these often degenerative, debilitating, and life-threatening conditions. So many more people can live better, healthier lives.

We believe we will achieve this through our talented teams and partners using scientific, medical and commercial innovation.

Our science is already starting to change the trajectory of care across chronic diseases. To continue to create the greatest and swiftest impact on disease, we are dedicated to enhancing disease understanding, broadening our therapeutic platforms, better predicting clinical outcomes and pioneering new approaches in the clinic. 

We are also transforming how we bring products to market while delivering innovative healthcare solutions and commercial strategies that further unlock the potential of our medicines. Working with patients, caregivers, advocacy groups, healthcare professionals, health systems, policy makers and more, we are pioneering new approaches along the entire continuum of care, including advanced disease management platforms and initiatives to ensure broad and equitable access to treatment.

All our work in BioPharmaceuticals is underpinned and empowered by digital technologies, data and AI. By harnessing these technologies, we are already making extraordinary advances. 

We know our people are key to realising our ambition, and we are committed to fostering a business and culture that attracts and retains the best, most talented and passionate people, and provides them with ample opportunity, resources and support to develop, grow and live up to their potential.

By having a clear vision combined with a unified approach, we are confident in our ability to push the boundaries and go beyond the ordinary to help improve billions of lives. So everyone with chronic diseases can live better, healthier lives.

If you believe in the power of what science can do and want to help us change the lives of billions of people for the better and address some of the biggest healthcare challenges facing humankind, join us: http://careers.ngskmc-eis.net/.

Topics: